Absolute Monocyte Count (AMC) Calculator
Absolute Monocyte Count (AMC) Calculator
Turn a white cell count and a monocyte percentage into the absolute monocyte count — and see why 0.5 ×10⁹/L now matters even though it sits inside the reference interval.
Absolute Monocyte Count (AMC)
WBC × % monocytesWBC 5.6 ×10⁹/L, monocytes 12%
Formula
- WBC
- white cell count, ×10⁹/L
- % monocytes
- the monocyte percentage from the differential — also, separately, one of the two arms of the CMML criterion
- 0.5 ×10⁹/L
- the absolute monocytosis threshold in the WHO 5th edition and ICC 2022 criteria for CMML, lowered from 1.0 ×10⁹/L
- both arms
- the criterion requires the absolute count AND monocytes ≥ 10% of the differential. Meeting one without the other does not satisfy it
Worked example
WBC 5.6 ×10⁹/L, monocytes 12%
5.6 × 12 ÷ 100 = 0.67 ×10⁹/L
Inside the usual adult reference interval of 0.2–0.8 ×10⁹/L, so most reports would not flag it
But it is above 0.5 ×10⁹/L and the monocytes are 12 per cent of the differential, so both arms of the current absolute-and-relative monocytosis criterion are met on this one sample
That is not a diagnosis. CMML needs the same picture persisting for three months, and between 0.5 and 1.0 ×10⁹/L the WHO also requires dysplasia together with a clonal abnormality
Bands, and the threshold that sits inside the reference interval
| AMC (×10⁹/L) | Category | What follows |
|---|---|---|
| < 0.2 | Monocytopenia | Usually steroids or general marrow suppression; if isolated and persistent, consider hairy cell leukaemia, aplastic anaemia or GATA2 deficiency |
| 0.2 – 0.5 | Normal | No action from the count |
| 0.5 – 0.8 | High-normal | Inside the reference interval, but at or above the CMML absolute threshold — only relevant if persistent, ≥ 10% of the differential, and supported |
| > 0.8 | Monocytosis | Reactive causes far outnumber clonal ones; persistence beyond three months changes the work-up |
Reactive against clonal monocytosis
| Reactive — much commoner | Clonal — much rarer |
|---|---|
| Recovery from neutropenia or after G-CSF | Chronic myelomonocytic leukaemia |
| Chronic infection: tuberculosis, endocarditis, brucellosis, visceral leishmaniasis | Juvenile myelomonocytic leukaemia in children |
| Inflammatory bowel disease, sarcoidosis, rheumatoid arthritis, systemic lupus | Acute myeloid leukaemia with monocytic differentiation |
| Malignancy, and the post-splenectomy state | Myelodysplastic syndrome and MDS/MPN overlap |
| Pregnancy, recovery phase of an acute illness | Chronic myeloid leukaemia, atypical CML |
A threshold that moved down, and a reference interval that did not
The absolute monocyte count is the white cell count multiplied by the monocyte percentage and divided by a hundred, and the usual adult reference interval is roughly 0.2 to 0.8 ×10⁹/L. What makes it worth its own page is a threshold that sits inside that interval. The 5th edition of the WHO classification, and the International Consensus Classification alongside it, lowered the absolute monocytosis figure in the chronic myelomonocytic leukaemia criteria from 1.0 to 0.5 ×10⁹/L — so a count that no laboratory flags as abnormal can now be the absolute arm of a diagnostic criterion.
That criterion has two arms, and both must be satisfied. It requires a persistent absolute monocyte count of 0.5 ×10⁹/L or more and monocytes accounting for 10 per cent or more of the white cell differential. A patient with a monocyte count of 0.7 ×10⁹/L on a white cell count of 12 has monocytes at only 6 per cent and does not meet it. The two arms exist precisely to stop a monocytosis that is simply part of a general leucocytosis from being read as a monocytic disorder.
The safeguards around the lowered figure matter as much as the figure itself. Persistence is required for at least three months. And where the absolute count is between 0.5 and 1.0 ×10⁹/L — the range now called oligomonocytic CMML — the WHO additionally requires a clonal cytogenetic or molecular abnormality together with documented dysplasia in at least one lineage. A single count of 0.6 ×10⁹/L, on its own, is a normal blood test, and reading it as anything else is the predictable misuse of a lowered threshold.
Because reactive monocytosis is far commoner than clonal disease, the practical work is almost always to identify the reaction. Monocytes rise in recovery from neutropenia and after G-CSF, in chronic infection such as tuberculosis, infective endocarditis, brucellosis and visceral leishmaniasis, in inflammatory bowel disease, sarcoidosis and the connective tissue diseases, in malignancy, and after splenectomy. A monocytopenia is the rarer and in some ways more specific finding: usually a corticosteroid effect or part of a general marrow suppression, but a persistent isolated absence of monocytes points at hairy cell leukaemia, aplastic anaemia or GATA2 deficiency and deserves a film rather than a repeat.
Frequently asked questions
What is a normal absolute monocyte count?
Roughly 0.2 to 0.8 ×10⁹/L in adults, though laboratories vary and some quote an upper limit of 1.0. Monocytosis is conventionally called above 0.8 ×10⁹/L, and monocytopenia below 0.2.
What monocyte count is used to diagnose CMML?
The WHO 5th edition and the ICC 2022 both require a persistent absolute monocyte count of 0.5 ×10⁹/L or more with monocytes at 10 per cent or more of the white cell differential, lowered from the previous 1.0 ×10⁹/L. Both arms are needed, plus persistence for three months.
Does a monocyte count of 0.6 mean I have CMML?
No. That is a normal blood test on its own. The criteria also need monocytes to be 10 per cent or more of the differential, persistence over three months, and — in the 0.5 to 1.0 ×10⁹/L range — a clonal abnormality together with documented dysplasia.
What causes a raised monocyte count?
Reactive causes overwhelmingly: recovery from neutropenia or G-CSF, chronic infection such as tuberculosis or endocarditis, inflammatory bowel disease, autoimmune disease, malignancy and the post-splenectomy state. Clonal causes such as CMML are far rarer.
What does a low monocyte count mean?
Usually corticosteroids or generalised marrow suppression. A persistent isolated monocytopenia is unusual and is a recognised feature of hairy cell leukaemia, aplastic anaemia and GATA2 deficiency, so it warrants a blood film rather than simply a repeat count.
Related calculators
References
- Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703–1719.
- Arber DA, Orazi A, Hasserjian RP, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias. Blood. 2022;140(11):1200–1228.
- Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. Am J Hematol. 2024;99(6):1142–1165.
Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.